December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
A novel Candidate Gene is Mutated in the Mouse retinal degeneration 6
Author Affiliations & Notes
  • S Kameya
    The Jackson Laboratory Bar Harbor ME
  • B Chang
    The Jackson Laboratory Bar Harbor ME
  • NL Hawes
    The Jackson Laboratory Bar Harbor ME
  • JR Heckenlively
    Jules Stein Eye Institute Harbor-UCLA Medical Center Torrance CA
  • JK Naggert
    The Jackson Laboratory Bar Harbor ME
  • PM Nishina
    The Jackson Laboratory Bar Harbor ME
  • Footnotes
    Commercial Relationships   S. Kameya, None; B. Chang, None; N.L. Hawes, None; J.R. Heckenlively, None; J.K. Naggert, None; P.M. Nishina, None. Grant Identification: NIH Grant EY11996
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 833. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S Kameya, B Chang, NL Hawes, JR Heckenlively, JK Naggert, PM Nishina; A novel Candidate Gene is Mutated in the Mouse retinal degeneration 6 . Invest. Ophthalmol. Vis. Sci. 2002;43(13):833.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: The retinal degeneration 6 (rd6) mouse mutation causes an autosomal recessive, progressive retinal degeneration similar to human retinitis punctata albescens. Fundus examination of mice homozygous for rd6 shows discrete dots distributed across the retina. The purpose of this study is to elucidate the molecular genetic defect of rd6 mice. Methods: We have used a positional cloning approach to identify the gene responsible for rd6. Previous genetic mapping had localized rd6 to mouse chromosome 9 approximately 24 cM from the centromere. To locate rd6 precisely, we constructed a high resolution genetic map of the region. A total of 657 F2 progeny from the C57BL/6J-rd6/rd6 x CAST intercross were genotyped with markers D9MIT329 and D9MIT23 and phenotyped using indirect ophthalmoscopy. A physical map of the critical area was assembled using bacterial artificial chromosome clones. Transcript map of the critical region was assembled using comparative in silica analysis. Candidate genes were tested by Northern blot , sequencing, and in situ hybridization analyses. Results: The maximum estimated genetic distance for the chromosome 9 segment containing rd6 was 0.45 cM (6 recombinants/1314 meiosis). One of the candidate genes showed an altered hybridization pattern to mRNA derived from rd6 mutant mice in that they expressed a slightly smaller transcript. By sequencing the corresponding cDNA derived from eyes of rd6, we found that exon 4 was missing. We also found 4 bp deletion in the splice donor sequence of intron 4 in rd6 genomic DNA. We examined the expression of the gene in adult tissues by Northern blot analysis and identified a 4.4 kb transcripts that is predominantly expressed in the eye and at a lower level in the brain. In situ hybridization showed that the mRNA of the gene is expressed in retinal pigment epithelium (RPE) and ciliary epithelium. Conclusions: We identified the disease causing mutation in rd6 mice, a model for human flecked retinal diseases. Spatial expression of the gene suggests that the interaction between photoreceptors and RPE may be central to the retinal degeneration seen in rd6.

Keywords: 316 animal model • 562 retinal degenerations: hereditary • 521 positional cloning 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.